{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T01:53:45Z","timestamp":1791597225536,"version":"4.3.4"},"reference-count":35,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0017665","type":"journal-article","created":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T16:49:49Z","timestamp":1301676589000},"page":"e17665","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":178,"title":["Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules"],"prefix":"10.1371","volume":"6","author":[{"given":"Anna","family":"Hultberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel J.","family":"Temperton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Rosseels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Koenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gonzalez-Pajuelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Schepens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena Itat\u00ed","family":"Iba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vanlandschoot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris","family":"Schillemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin A.","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Saelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Melero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Theo","family":"Verrips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Van Gucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans J.","family":"de Haard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,4,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1146\/annurev.biochem.78.082207.084029","article-title":"New antivirals and drug resistance.","volume":"78","author":"PM Colman","year":"2009","journal-title":"Annu Rev Biochem"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/jac\/dkn014","article-title":"Hepatitis B virus escape mutants induced by antiviral therapy.","volume":"61","author":"J Sheldon","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"12069","DOI":"10.1128\/JVI.01379-08","article-title":"Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120.","volume":"82","author":"A Forsman","year":"2008","journal-title":"J Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"9753","DOI":"10.1128\/JVI.00436-08","article-title":"Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice.","volume":"82","author":"L Garaicoechea","year":"2008","journal-title":"J Virol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2006.02.045","article-title":"Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments.","volume":"24","author":"JM van der Vaart","year":"2006","journal-title":"Vaccine"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.22609","article-title":"Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice.","volume":"49","author":"B Serruys","year":"2009","journal-title":"Hepatology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1002\/art.21827","article-title":"Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis.","volume":"54","author":"K Coppieters","year":"2006","journal-title":"Arthritis Rheum"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00262-006-0180-4","article-title":"Efficient inhibition of EGFR signaling and of tumour growth by antagonistic anti-EFGR Nanobodies.","volume":"56","author":"RC Roovers","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains.","volume":"363","author":"C Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00253-007-1142-2","article-title":"Properties, production, and applications of camelid single-domain antibody fragments.","volume":"77","author":"MM Harmsen","year":"2007","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jmb.2005.04.049","article-title":"Ultra-potent Antibodies Against Respiratory Syncytial Virus: Effects of Binding kinetics and Binding Valence on Viral Neutralization.","volume":"350","author":"H Wu","year":"2005","journal-title":"J Mol Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1128\/JVI.63.7.2941-2950.1989","article-title":"Neutralization epitopes of the F protein of respiratory syncytial virus: effect of mutation upon fusion function.","volume":"63","author":"JA Beeler","year":"1989","journal-title":"J Virol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/viro.1998.9462","article-title":"Monoclonal antibody-resistant mutants selected with a Respiratory Syncytial virus-neutralizing epitope on the Fusion (F) glycoprotein.","volume":"252","author":"JE Crowe","year":"1998","journal-title":"Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1099\/vir.0.82753-0","article-title":"Characterization of the epitope for anti-human respiratory syncytial virus F protein monoclonal antibody 101F using synthetic peptides and genetic approaches.","volume":"88","author":"SJ Wu","year":"2007","journal-title":"J Gen Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1128\/JVI.72.8.6922-6928.1998","article-title":"Antigenic structure of human respiratory syncytial virus fusion glycoprotein.","volume":"72","author":"JA L\u00f3pez","year":"1998","journal-title":"J Virol"},{"key":"ref16","first-page":"105","article-title":"A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Resp.","volume":"1","author":"NJ Temperton","year":"2007","journal-title":"Viruses"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.","volume":"3","author":"M Throsby","year":"2008","journal-title":"PLoS One"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.20506\/rst.12.1.663","article-title":"The ecology of dogs and canine rabies: a selective review.","volume":"12","author":"AI Wandeler","year":"1993","journal-title":"Rev Sci Tech"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1017\/S0950268803001481","article-title":"European bat lyssaviruses: an emerging zoonosis.","volume":"131","author":"AR Fooks","year":"2003","journal-title":"Epidemiol Infect"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/0264-410X(93)90052-Y","article-title":"Protective activity of a murine monoclonal antibody against European bat lyssavirus 1 (EBL1) infection in mice.","volume":"11","author":"JA Monta\u00f1o-Hirose","year":"1993","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1086\/514115","article-title":"Development of a Humanized Monoclonal Antibody (MEDI-493) With Potent In Vitro and In Vivo Activity Against Respiratory Syncytial Virus.","volume":"176","author":"S Johnson","year":"1997","journal-title":"J Infect Dis"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"18363","DOI":"10.1073\/pnas.0708865104","article-title":"VEGF Trap complex formation measures production rates of VEGF, providing a biomarker for predicting efficacious angiogenic blockade.","volume":"104","author":"JS Rudge","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1086\/423213","article-title":"Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants.","volume":"190","author":"JP DeVincenzo","year":"2004","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nm1244","article-title":"Delay of HIV-1 rebound after cessation of antiretroviral therapy through passive transfer of human neutralizing antibodies.","volume":"6","author":"A Trkola","year":"2005","journal-title":"Nat Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","article-title":"Novel Human Monoclonal Antibody Combination Effectively Neutralizing Natural Rabies Virus Variants and Individual In Vitro Escape Mutants.","volume":"79","author":"AB Bakker","year":"2005","journal-title":"J Virol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1099\/0022-1317-78-10-2431","article-title":"Variations in the neutralizing and haemagglutination-inhibiting activities of five influenza A virus-specific IgGs and their antibody fragments.","volume":"78","author":"DJ Schofield","year":"1997","journal-title":"J Gen Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1073\/pnas.0811427106","article-title":"Examination of the contributions of size and avidity to the neutralization mechanisms of the anti-HIV antibodies b12 and 4E10.","volume":"106","author":"JS Klein","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1073\/pnas.0505379103","article-title":"Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies.","volume":"A103","author":"E De Genst","year":"2006","journal-title":"Proc Natl Acad Sci U S"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1074\/jbc.M007734200","article-title":"Camel Single-domain Antibodies as Modular Building Units in Bispecific and Bivalent Antibody Constructs.","volume":"276","author":"KE Conrath","year":"2001","journal-title":"JBC"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.coph.2008.07.006","article-title":"Single-domain antibodies as building blocks for novel therapeutics.","volume":"8","author":"D Saerens","year":"2008","journal-title":"Curr Opin Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1472-6750-7-17","article-title":"High level expression of soluble glycoproteins in the allantoic fluid of embryonated chicken eggs using a Sendai virus minigenome system.","volume":"7","author":"T Corral","year":"2007","journal-title":"BMC Biotechnol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1128\/JVI.63.2.925-932.1989","article-title":"Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins.","volume":"63","author":"B Garc\u00eda-Barreno","year":"1989","journal-title":"J Virol"},{"key":"ref33","first-page":"Quarter 1","article-title":"Two cases of imported canine rabies in the Brussels area within six months time.","volume":"32","author":"I Le Roux","year":"2008","journal-title":"WHO Rabies Bulletin"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1128\/JCM.30.9.2419-2426.1992","article-title":"Antigenic and molecular characterization of bat rabies virus in Europe.","volume":"30","author":"H Bourhy","year":"1992","journal-title":"J Clin Microbiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1073\/pnas.75.8.3938","article-title":"Monoclonal antibodies against rabies virus produced by somatic cell hybridization: detection of antigenic variants.","volume":"75","author":"TJ Wiktor","year":"1978","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0017665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T16:34:58Z","timestamp":1592411698000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0017665"}},"subtitle":[],"editor":[{"given":"Eric","family":"Kremer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,4,1]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,4,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0017665","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.9958956.10689054","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,1]]}}}